Global markets for osteoporosis drugs and technologies to reach $9.7 billion by 2014

The global market for drugs that treat and prevent osteoporosis declined to $8 billion in 2009 (as compared to $8.4 billion in 2008), but is expected to grow to $9.7 billion in 2014, showing a compound annual growth rate (CAGR) of 3.8% between 2009 and 2014.

Learn about the osteoporosis drugs currently on the market in six major classes; get an analysis of the market trends through 2014 along with a breakdown of the industry structure and comprehensive company profiles...

Use this report to:

• Receive an understanding of the global market for prescription drugs that treat and prevent osteoporosis focusing on industry structure and major participants in the osteoporosis drugs market, market dynamics and competitive aspects, current developments and future market trends to assist in understanding the market and identifying areas of commercial interest and potential in osteoporosis
• Understand and assess the current market status along with an analysis of the patient population, marketed drugs, market revenues, and company shares
• See 5 year future market revenue forecasts for the global market, major drug classes and the largest geographical regions, as well as the reviews of the compounds being investigated in clinical studies for the treatment of osteoporosis from 2009 through 2014
• Determine future developments in the osteoporosis drugs market covering the period from 2007 through 2014, while describing the existing drug classes approved for these indications, including bisphosphonates, selective estrogen receptor modulators (SERMS), parathyroid hormones (PTHs), calcitonins, dual-action bone agents (DABAs), and hormone replacement therapies (HRTs).

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

Ophthalmic Therapeutic Drugs: Technologies and Global Markets

The overall ophthalmic sector grew to $15.5 billion in 2009 (as compared to $14.4 billion in 2008) and is expected to grow to $20.6 billion in 2014, showing a compound annual growth rate (CAGR) of 5.9%.

Learn about the market for ophthalmic drugs and get forecasts by product, product category, and by company from 2009 through 2014...

Use this report to:

• Receive current and projected product forecasts during the forecast period (2009 to 2014) as well as new products approved in 2009 by the FDA and those products expected to be approved within the forecast period
• Understand emerging markets by disease segment as an aging demographic that will change the market dynamic, emerging players and technologies, strategies for accessing emerging markets and specific disease segments and geographies in order to allocate resources and make effective decisions
• See 5 year projections and trends that quantify, forecast and analyze the market for ophthalmic drugs, and to provide a range of market information from detailed product analysis within disease subsegments to overall industry trends
• Determine the most important market drivers: the introduction of combination therapies, which are expected to continue to contribute substantially to market growth through the forecast period.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

Global market for autacoids and related drugs to be worth $112.6 billion by 2015

Global sales of autacoids and related drugs in 2008 were $95.1 billion, which declined to $94.6 billion in 2009. However, the market is expected to rise at a compound annual growth rate (CAGR) of 3.2% to reach $112.6 billion by 2015.
Learn about the present and future strategies within the autacoids and related drug market, including the biogenic amines, polypeptide derivatives, lipid-derived autacoids, and endothelium-derived autacoids...

Use this report to:

• Receive comprehensive analysis of the current market for autacoids and related drugs and its future direction, while examining the x biologic activity and usage of autacoids in the treatment of various diseases.
• Understand the present and future strategies within the autacoids and related drug market, including the biogenic amines, polypeptide derivatives, lipid-derived autacoids, and endothelium-derived autacoids.
• See 5-year forecasts and trends based on detailed analysis of the structure of commerce in autacoids and related products, including all four major categories of autacoid-related products, further divided into subcategories and revenues broken down by region and subcategories from 2010 through 2015.
• Determine the applications for autacoids and related products utilizing their therapeutic benefits, with emphasis on results in respiratory, cardiovascular, CNS, analgesics, and antiemetics.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

Global market for infectious disease treatments worth $137.9 billion by 2014

The global market for infectious disease treatments was nearly $90.4 billion in 2009 and is projected to increase to $137.9 billion by 2014, for a 5-year compound annual growth rate (CAGR) of 8.8%.

Learn about the worldwide demand for infectious disease prevention and treatment products, their markets, and growth opportunities...

Use this report to:

• Receive detailed analysis of the global infectious disease market with technological developments, future trends, and emerging opportunities
• Determine the worldwide demand for infectious disease prevention and treatment products, their markets and growth opportunities, as well as the increasing concern regarding antibiotic-resistant organisms and their sometimes-fatal effects on humans
• See 5 year projections of the global supply and demand for each disease type  as well as products types with demand growing for newer pharmaceutical treatments, vaccines and environmental products
• Understand global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and industrial products, an applicable patents.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.